Oropharynx (OPX) Biomarker Trial

NCT06356272 · clinicaltrials.gov ↗

RECRUITING

Status

560

Enrollment

OTHER

Sponsor class

Conditions

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Metastatic Oropharyngeal Squamous Cell Carcinoma
Oropharyngeal Squamous Cell Carcinoma
Recurrent Oropharyngeal Squamous Cell Carcinoma
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Head and Neck Carcinoma
Head and Neck Neoplasm
Salivary Gland Neoplasms
Thyroid Gland Neoplasm

Interventions

OTHER: Non-Interventional Study

Sponsor

Mayo Clinic